a year ago
IOVA
AnalystsAsthika GoonewardeneAsthika Goonewardene's Stock Forecasts
AnalystsAsthika Goonewardene
Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4667 out of 4868 analysts
Average Return
-9.77%
Win Rate
35%30 out of 85
Risk vs Reward
Poor
Good
Asthika Goonewardene's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +180.83% | $5.32 | $14.94 | 2022-11-20 - 2023-11-20 | Strong Buy |
Forty Seven IncFTSV | +163.68% | $35.74 | $94.24 | 2020-01-12 - 2020-03-03 | Strong Buy |
Sutro Biopharma IncSTRO | +111.24% | $12.01 | $25.37 | 2020-01-12 - 2021-01-13 | Strong Buy |
Immunogen IncIMGN | +106.14% | $15.15 | $31.23 | 2023-06-05 - 2024-02-09 | Strong Buy |
Iovance Biotherapeutics IncIOVA | +96.20% | $5.27 | $10.34 | 2023-09-14 - 2024-09-13 | Strong Buy |
Asthika Goonewardene Analyst Color
Get additional color on Asthika Goonewardene's coverage of popular stocks
a year ago
ACLX
Asthika Goonewardene's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Autolus Therapeutics PLCAUTL | 4 | Strong Buy | $10.00 | +609.22% | Maintains | a month ago |
Genmab AGMAB | 12 | Strong Buy | $45.00 | +112.77% | Maintains | 2 months ago |
Iovance Biotherapeutics IncIOVA | 6 | Strong Buy | $15.00 | +317.83% | Maintains | 2 months ago |
Cargo Therapeutics IncCRGX | 3 | Hold | $7.00 | +53.17% | Downgrades | 3 months ago |
Exelixis IncEXEL | 7 | Strong Buy | $43.00 | +9.83% | Maintains | 3 months ago |
Igm Biosciences IncIGMS | 8 | Hold | $2.00 | +44.40% | Maintains | 4 months ago |
Biontech SeBNTX | 1 | Strong Buy | $172.00 | +65.15% | Initiates Coverage On | 4 months ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $35.00 | +45.11% | Initiates Coverage On | 4 months ago |
Arcellx IncACLX | 5 | Strong Buy | $136.00 | +109.39% | Maintains | 6 months ago |
Gilead Sciences IncGILD | 1 | Hold | $97.00 | -8.95% | Maintains | 6 months ago |
Sutro Biopharma IncSTRO | 6 | Strong Buy | $15.00 | +1,328.57% | Maintains | 8 months ago |
Allogene Therapeutics IncALLO | 5 | Strong Buy | $14.00 | +733.33% | Reiterates | 9 months ago |
Arcus Biosciences IncRCUS | 1 | Strong Buy | $44.00 | +402.86% | Maintains | 10 months ago |
Legend Biotech CorpLEGN | 1 | Strong Buy | $88.00 | +151.79% | Initiates Coverage On | 10 months ago |
Merus NvMRUS | 2 | Strong Buy | $88.00 | +93.36% | Maintains | a year ago |
Compugen LtdCGEN | 5 | Strong Buy | $4.00 | +150.00% | Maintains | a year ago |
Caribou Biosciences IncCRBU | 3 | Strong Buy | $19.00 | +2,132.67% | Maintains | a year ago |
Mersana Therapeutics IncMRSN | 2 | Strong Buy | $9.00 | N/A | Upgrades | a year ago |
Seagen IncSGEN | 3 | Hold | $229.00 | N/A | Reiterates | 2 years ago |
Hookipa Pharma IncHOOK | 4 | Strong Buy | $40.00 | N/A | Reiterates | 2 years ago |
Adicet Bio IncACET | 2 | Strong Buy | $27.00 | N/A | Reiterates | 2 years ago |
Immunogen IncIMGN | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Instil Bio IncTIL | 1 | Hold | $120.00 | N/A | Reinstates | 2 years ago |
Tcr2 Therapeutics IncTCRR | 3 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
Harpoon Therapeutics IncHARP | 3 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Celularity IncCELU | 2 | Hold | $60.00 | N/A | Maintains | 3 years ago |
Nextcure IncNXTC | 4 | Strong Buy | $15.00 | N/A | Maintains | 3 years ago |
Forty Seven IncFTSV | 2 | Hold | $95.50 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.